EXCHANGE AGREEMENTExchange Agreement • February 19th, 2020 • Novus Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 19th, 2020 Company Industry JurisdictionThis Exchange Agreement (the “Agreement”), dated as of February 13, 2020 (the “Effective Date”), is entered into by and among Novus Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of the Company’s common stock, par value $0.001 per share (the “Common Stock”) listed on Schedule I attached hereto (each a “Stockholder” and collectively, the “Stockholders” and, together with the Company, the “Parties”).